Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: A cohort study

Table 1 Patients’ demographic characteristics and etiology of liver cirrhosis n (%)

	Patients
Patients number	117
Gender
Male	81 (69.2)
Female	36 (30.8)
Age (yr)
mean ± SD	69 ± 7.8
Range	43-85
Causes of cirrhosis
HBV (hepatitis B)	9 (7.7)
HBV and NAFLD	5 (4.3)
HBV and alcohol abuse	1 (0.09)
HCV (hepatitis C)	59 (50.4)
HCV and NAFLD	16 (13.7)
HCV and alcohol abuse	10 (8.5)
Alcohol abuse	8 (6.8)
Alcohol abuse and overweight	8 (6.8)
Sarcoidosis	1 (0.09)

NAFLD: Non-alcoholic fatty liver disease.

Table 2 Child-Pugh and CLIP score in 71 patients eligible for TACE at enrollment (mean ± SD)

	Not pretreated patients	Previously treated patients
Number of patients	39	32
Child-Pugh score	5.82 ± 0.82	5.4 ± 1.2
CLIP score	1.12 ± 0.82	0.86 ± 0.83